Our focus is expanding affordable access to NARCAN® (naloxone HCl) Nasal Spray - the leading
community use naloxone - and progressing our pipeline of opioid overdose and addiction treatments.

MENU

We Want to Partner With You

As Adapt Pharma builds and grows, we are interested in collaborating with partners from around the globe. Our focus is on novel therapeutic medicines that can positively affect the lives of patients with specialty medical conditions. Currently, ADAPT markets NARCAN® Nasal Spray in the United States and Canada. The company is also researching and developing additional product candidates for opioid overdose and for the treatment of opioid addiction.

If you have an opportunity from mid-clinical development through the commercial stage, we welcome the opportunity to speak or meet with you. Please email or contact Adapt Pharma at:

bd@adaptpharma.com

Tel: +353-1-6344-172